Answers are grounded in this paper and cite their sources.
A versatile synthetic approach to the tulearin class of macrolactones has been developed and deployed to make a stereoisomer of tulearin A. The knowledge gained about structure and synthesis will expedite the assignment of the stereostructure of this new anticancer agent.
No takes yet. Share an insight, caveat, or question.
Mandel et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: